Citations (195)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Timothy M. E. Davis, Brioni R. Moore, Sam Salman, Madhu Page-Sharp, Kevin T. Batty & Laurens Manning. (2016) Use of quantitative pharmacology tools to improve malaria treatments. Expert Review of Clinical Pharmacology 9:2, pages 303-316.
Read now
Read now
Huaiye Zhang, Inyoung Kim & Chun Gun Park. (2014) Semiparametric Bayesian hierarchical models for heterogeneous population in nonlinear mixed effect model: application to gastric emptying studies. Journal of Applied Statistics 41:12, pages 2743-2760.
Read now
Read now
Inna Chervoneva, Tingting Zhan, Boris Iglewicz, Walter
W. Hauck & David
E. Birk. (2012) Two-stage hierarchical modeling for analysis of subpopulations in conditional distributions. Journal of Applied Statistics 39:2, pages 445-460.
Read now
Read now
Emmanuelle Comets & France Mentré. (2001) EVALUATION OF TESTS BASED ON INDIVIDUAL VERSUS POPULATION MODELING TO COMPARE DISSOLUTION CURVES. Journal of Biopharmaceutical Statistics 11:3, pages 107-123.
Read now
Read now
. (1997) Book Reviews. Journal of the American Statistical Association 92:438, pages 788-798.
Read now
Read now
Jon Wakefield. (1996) The Bayesian Analysis of Population Pharmacokinetic Models. Journal of the American Statistical Association 91:433, pages 62-75.
Read now
Read now
Alison A. Carter, Sara E. Rosenbaum & Michael N. Dudley. (1995) Review of Methods in Population Pharmacokinetics. Clinical Research and Regulatory Affairs 12:1, pages 1-21.
Read now
Read now
Sara E. Rosenbaum, Alison A. Carter & Michael N. Dudley. (1995) Population Pharmacokinetics: Fundamentals, Methods and Applications. Drug Development and Industrial Pharmacy 21:9, pages 1115-1141.
Read now
Read now
France Mentré & Roberto Gomeni. (1995) A Two-Step Iterative Algorithm For Estimation In Nonlinear Mixed-Effect Models With An Evaluation In Population Pharmacokinetics. Journal of Biopharmaceutical Statistics 5:2, pages 141-158.
Read now
Read now
C.
Joseph Lu & WilliamO. Meeker. (1993) Using Degradation Measures to Estimate a Time-to-Failure Distribution. Technometrics 35:2, pages 161-174.
Read now
Read now
Marie Davidian & David M. Giltinan. (1993) Some general estimation methods for nonlinear mixed-effects model. Journal of Biopharmaceutical Statistics 3:1, pages 23-55.
Read now
Read now
MarciaL. Gumpertz & SastryG. Pantula. (1992) Nonlinear Regression with Variance Components. Journal of the American Statistical Association 87:417, pages 201-209.
Read now
Read now
Articles from other publishers (183)
Natalia Riva, Lucas Brstilo, Aymara Sancho-Araiz, Manuel Molina, Andrea Savransky, Georgina Roffé, Marianela Sanz, Silvia Tenembaum, Maria M. Katsicas, Iñaki F. Trocóniz & Paula Schaiquevich. (2023) Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases. Pharmaceutics 15:11, pages 2534.
Crossref
Crossref
Yue Zhang & Ben Boukai. (2021) Recycled two-stage estimation in nonlinear mixed effects regression models. Statistical Methods & Applications 31:3, pages 551-585.
Crossref
Crossref
Margareta Bego, Nikunjkumar Patel, Rodrigo Cristofoletti & Amin Rostami-Hodjegan. (2022) Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling. The AAPS Journal 24:1.
Crossref
Crossref
Sylvain Goutelle, Jean‐Baptiste Woillard, Michael Neely, Walter Yamada & Laurent Bourguignon. (2020) Nonparametric Methods in Population Pharmacokinetics. The Journal of Clinical Pharmacology 62:2, pages 142-157.
Crossref
Crossref
Tim Preijers, Lisette M. Schütte, Marieke J. H. A. Kruip, Marjon H. Cnossen, Frank W. G. Leebeek, Reinier M. van Hest & Ron A. A. Mathôt. (2020) Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia. Clinical Pharmacokinetics 60:1, pages 1-16.
Crossref
Crossref
Henrik Bjugård Nyberg, Andrew C. Hooker, Robert J. Bauer & Yasunori Aoki. (2020) Saddle-Reset for Robust Parameter Estimation and Identifiability Analysis of Nonlinear Mixed Effects Models. The AAPS Journal 22:4.
Crossref
Crossref
Robert J. Bauer. (2019) NONMEM Tutorial Part II: Estimation Methods and Advanced Examples. CPT: Pharmacometrics & Systems Pharmacology 8:8, pages 538-556.
Crossref
Crossref
Nithya Srinivas, Sarah Beth Joseph, Kevin Robertson, Laura P. Kincer, Prema Menezes, Lourdes Adamson, Amanda P. Schauer, Kimberly H. Blake, Nicole White, Craig Sykes, Paul Luciw, Joseph J. Eron, Alan Forrest, Richard W. Price, Serena Spudich, Ronald Swanstrom & Angela D.M. Kashuba. (2019)
Predicting Efavirenz Concentrations in the Brain Tissue of
HIV
‐Infected Individuals and Exploring their Relationship to Neurocognitive Impairment
. Clinical and Translational Science 12:3, pages 302-311.
Crossref
Crossref
Lekshmi Dharmarajan, Hans-Michael Kaltenbach, Fabian Rudolf & Joerg Stelling. (2019) A Simple and Flexible Computational Framework for Inferring Sources of Heterogeneity from Single-Cell Dynamics. Cell Systems 8:1, pages 15-26.e11.
Crossref
Crossref
Eleni I. Georga, Dimitrios I. Fotiadis & Stelios K. Tigas. 2018. Personalized Predictive Modeling in Type 1 Diabetes. Personalized Predictive Modeling in Type 1 Diabetes
61
96
.
Elizabeth A Lakota, Justin C Bader & Christopher M Rubino. (2017) Ensuring quality pharmacokinetic analyses in antimicrobial drug development programs. Current Opinion in Pharmacology 36, pages 139-145.
Crossref
Crossref
Fernando Garc?a-Garc?a, Roman Hovorka, Malgorzata E. Wilinska, Daniela Elleri & M. Elena Hernando. (2016) Modelling the effect of insulin on the disposal of meal-attributable glucose in type 1 diabetes. Medical & Biological Engineering & Computing 55:2, pages 271-282.
Crossref
Crossref
Hongshuo Song, Bhavna Hora, Elena E. Giorgi, Amit Kumar, Fangping Cai, Tanmoy Bhattacharya, Alan S. Perelson & Feng Gao. (2016) Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences. Scientific Reports 6:1.
Crossref
Crossref
Sujata M. Bhavnani, Christopher M. Rubino & Paul G. Ambrose. 2016. Antibiotic Pharmacodynamics. Antibiotic Pharmacodynamics
127
157
.
Eric L. Haseltine, Holly Kimko, Haobin Luo, John Tolsma, Doug J. Bartels, Tara L. Kieffer & Varun Garg. (2015) Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies. Journal of Pharmacokinetics and Pharmacodynamics 42:6, pages 681-698.
Crossref
Crossref
Martin Berglund, Martin Adiels, Marja-Riitta Taskinen, Jan Bor?n & Bernt Wennberg. (2015) Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models. PLOS ONE 10:9, pages e0138538.
Crossref
Crossref
Jean-Baptiste Woillard, Franck Saint-Marcoux, Caroline Monchaud, Rym Youdar?ne, Lucie Pouche & Pierre Marquet. (2015) Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients. Pharmacological Research 99, pages 308-315.
Crossref
Crossref
THT Nguyen & J Guedj. (2015) HCV Kinetic Models and Their Implications in Drug Development. CPT: Pharmacometrics & Systems Pharmacology 4:4, pages 231-242.
Crossref
Crossref
Xiao Hu, Yue Cui, Joleen White, Ying Zhu, Aaron Deykin, Ivan Nestorov & Serena Hung. (2015)
Pharmacokinetics and pharmacodynamics of peginterferon beta‐1a in patients with relapsing‐remitting multiple sclerosis in the randomized
ADVANCE
study
. British Journal of Clinical Pharmacology 79:3, pages 514-522.
Crossref
Crossref
Mehdi Boroujerdi. 2015. Pharmacokinetics and Toxicokinetics. Pharmacokinetics and Toxicokinetics
479
488
.
Seongho Kim, Adam E Gaweda, Dongfeng Wu, Lang Li, Shesh N Rai & Michael E Brier. (2015) SIMPLIFIED WARFARIN DOSE–RESPONSE PHARMACODYNAMIC MODELS. Biomedical Engineering: Applications, Basis and Communications 27:01, pages 1550001.
Crossref
Crossref
Jean-Baptiste Woillard, Vincent Lebreton, Michael Neely, Pascal Turlure, St?phane Girault, Jean Debord, Pierre Marquet & Franck Saint-Marcoux. (2014) Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients. British Journal of Clinical Pharmacology 78:4, pages 836-846.
Crossref
Crossref
Julie A. Simpson, Sophie Zaloumis, Alysha M. DeLivera, Ric N. Price & James M McCaw. (2014) Making the Most of Clinical Data: Reviewing the Role of Pharmacokinetic-Pharmacodynamic Models of Anti-malarial Drugs. The AAPS Journal 16:5, pages 962-974.
Crossref
Crossref
Joel S. Owen & Jill Fiedler-Kelly. 2014. Introduction to Population Pharmacokinetic / Pharmacodynamic Analysis with Nonlinear Mixed Effects Models. Introduction to Population Pharmacokinetic / Pharmacodynamic Analysis with Nonlinear Mixed Effects Models
1
8
.
?sa M. Johansson, Sebastian Ueckert, Elodie L. Plan, Andrew C. Hooker & Mats O. Karlsson. (2014) Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7. Journal of Pharmacokinetics and Pharmacodynamics 41:3, pages 223-238.
Crossref
Crossref
Kacie M. Dickinson, Peter M. Clifton, Louise M. Burrell, P. Hugh R. Barrett & Jennifer B. Keogh. (2014) Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function. Atherosclerosis 232:1, pages 211-216.
Crossref
Crossref
Stina Syvänen & Roger N. Gunn. 2014. Drug Delivery to the Brain. Drug Delivery to the Brain
213
232
.
Annemarie R Kreeftmeijer-Vegter, Mariana de Mendonça Melo, Peter J de Vries, Rob Koelewijn, Jaap J van Hellemond & Perry JJ van Genderen. (2013) Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria. Malaria Journal 12:1.
Crossref
Crossref
Julie A. Simpson, Kris M. Jamsen, Tim J. C. Anderson, Sophie Zaloumis, Shalini Nair, Charles Woodrow, Nicholas J. White, Francois Nosten & Ric N. Price. (2013) Nonlinear Mixed-Effects Modelling of In Vitro Drug Susceptibility and Molecular Correlates of Multidrug Resistant Plasmodium falciparum. PLoS ONE 8:7, pages e69505.
Crossref
Crossref
Donghui Zhang, Chunpeng Fan & A Gould. 2012. Encyclopedia of Biopharmaceutical Statistics, Third Edition. Encyclopedia of Biopharmaceutical Statistics, Third Edition
813
816
.
Elodie L. Plan, Alan Maloney, France Mentré, Mats O. Karlsson & Julie Bertrand. (2012) Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose–Response Models. The AAPS Journal 14:3, pages 420-432.
Crossref
Crossref
P Balasubramanian, S Desire, J C Panetta, K M Lakshmi, V Mathews, B George, A Viswabandya, M Chandy, R Krishnamoorthy & A Srivastava. (2012) Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT. Bone Marrow Transplantation 47:9, pages 1178-1185.
Crossref
Crossref
O. A. CHIESA, H. LI, P. J. KIJAK, J. X. LI, V. LANCASTER, M. L. SMITH, D. N. HELLER, M. H. THOMAS & J. Von BREDOW. (2012) Tissue/fluid correlation study for the depletion of sulfadimethoxine in bovine kidney, liver, plasma, urine, and oral fluid. Journal of Veterinary Pharmacology and Therapeutics 35:3, pages 249-258.
Crossref
Crossref
Franck Saint-Marcoux. 2012. Therapeutic Drug Monitoring. Therapeutic Drug Monitoring
103
119
.
Feng Jin. 2012. Development of Antibody-Based Therapeutics. Development of Antibody-Based Therapeutics
303
330
.
Philippe Colucci, Julie Grenier, Corinne Seng Yue, Jacques Turgeon & Murray P Ducharme. (2011) Performance of Different Population Pharmacokinetic Algorithms. Therapeutic Drug Monitoring 33:5, pages 583-591.
Crossref
Crossref
Anne Dubois, Marc Lavielle, Sandro Gsteiger, Etienne Pigeolet & France Mentré. (2011) Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm. Statistics in Medicine 30:21, pages 2582-2600.
Crossref
Crossref
Li Zhu, Fushing Hsieh, Juan Li & Eric Chi. (2011) Modeling subject-specific phase-dependent effects and variations in longitudinal responses via a geometric Brownian motion process. Statistics in Medicine 30:19, pages 2435-2450.
Crossref
Crossref
Jurgen B. Bulitta & Cornelia B. Landersdorfer. (2011) Performance and Robustness of the Monte Carlo Importance Sampling Algorithm Using Parallelized S-ADAPT for Basic and Complex Mechanistic Models. The AAPS Journal 13:2, pages 212-226.
Crossref
Crossref
Dacheng Liu, Tao Lu, Xu-Feng Niu & Hulin Wu. (2011) Mixed-Effects State-Space Models for Analysis of Longitudinal Dynamic Systems. Biometrics 67:2, pages 476-485.
Crossref
Crossref
Franck Saint-Marcoux, Soizic Vandierdonck, Aurélie Prémaud, Jean Debord, Annick Rousseau & Pierre Marquet. (2011) Large Scale Analysis of Routine Dose Adjustments of Mycophenolate Mofetil Based on Global Exposure in Renal Transplant Patients. Therapeutic Drug Monitoring 33:3, pages 285-294.
Crossref
Crossref
José Miguel Laínez, Gary Blau, Linas Mockus, Seza Orçun & Gintaras V. Reklaitis. (2011) Pharmacokinetic Based Design of Individualized Dosage Regimens Using a Bayesian Approach. Industrial & Engineering Chemistry Research 50:9, pages 5114-5130.
Crossref
Crossref
F. Saint-Marcoux, V. Guigonis, S. Decramer, P. Gandia, B. Ranchin, F. Parant, L. Bessenay, F. Libert, J. Harambat, S. Bouchet, F. Broux, P. Compagnon & P. Marquet. (2011) Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome. Pharmacological Research 63:5, pages 423-431.
Crossref
Crossref
Giampaolo Tomasi, Alessandra Bertoldo, Claudio Cobelli, Nicola Pavese, Yen. F. Tai, Alexander Hammers & Federico E. Turkheimer. (2011) Global-two-stage filtering of clinical PET parametric maps: Application to [11C]-(R)-PK11195. NeuroImage 55:3, pages 942-953.
Crossref
Crossref
Peter L. BonatePeter L. Bonate. 2011. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. Pharmacokinetic-Pharmacodynamic Modeling and Simulation
101
130
.
Jiang Liu & Hartmut Derendorf. 2010. Addictive Disorders in Medical Populations. Addictive Disorders in Medical Populations
107
124
.
Inyoung Kim, Noah D. Cohen, Allen Roussel & Naisyin Wang. (2010) A two‐component nonlinear mixed effects model for longitudinal data, with application to gastric emptying studies. Statistics in Medicine 29:17, pages 1839-1856.
Crossref
Crossref
Shein-Chung ChowDonghui Zhang, Chunpeng Fan & A.Lawrence Gould. 2010. Encyclopedia of Biopharmaceutical Statistics. Encyclopedia of Biopharmaceutical Statistics
813
816
.
Paolo DentiAlessandra BertoldoPaolo Vicini & Claudio Cobelli. (2010) IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach. American Journal of Physiology-Endocrinology and Metabolism 298:5, pages E950-E960.
Crossref
Crossref
Jason A. Roberts, Carl M.J. Kirkpatrick, Michael S. Roberts, Andrew J. Dalley & Jeffrey Lipman. (2010) First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. International Journal of Antimicrobial Agents 35:2, pages 156-163.
Crossref
Crossref
Franck Saint-Marcoux, Bernard Royer, Jean Debord, Fabrice Larosa, Faezeh Legrand, Eric Deconinck, Jean-Pierre Kantelip & Pierre Marquet. (2009) Pharmacokinetic Modelling and Development of Bayesian Estimators for Therapeutic Drug Monitoring of Mycophenolate Mofetil in Reduced-Intensity Haematopoietic Stem Cell Transplantation. Clinical Pharmacokinetics 48:10, pages 667-675.
Crossref
Crossref
P. Denti, A. Bertoldo, P. Vicini & C. Cobelli. (2009) Nonlinear Mixed Effects to Improve Glucose Minimal Model Parameter Estimation: A Simulation Study in Intensive and Sparse Sampling. IEEE Transactions on Biomedical Engineering 56:9, pages 2156-2166.
Crossref
Crossref
Corinne Yue, Pina D?Angelo & Murray Ducharme. 2009. International Pharmaceutical Product Registration, Second Edition. International Pharmaceutical Product Registration, Second Edition
537
553
.
Giampaolo Tomasi, Alessandra Bertoldo & Claudio Cobelli. (2008) PET Parametric Imaging Improved by Global-Two-Stage Method. Annals of Biomedical Engineering 37:2, pages 419-427.
Crossref
Crossref
Paolo Vicini. 2009. Handbook of Research on Systems Biology Applications in Medicine. Handbook of Research on Systems Biology Applications in Medicine
556
571
.
X. Liu, P. Kruger & M. S. Roberts. 2009. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine
859
869
.
X. Liu, P. Kruger & M. S. Roberts. 2009. Intensive Care Medicine. Intensive Care Medicine
859
869
.
Paolo Denti, Paolo Vicini, Alessandra Bertoldo & Claudio Cobelli. (2008) Glucose Minimal Model population analysis: Likelihood function profiling via Monte Carlo sampling. Glucose Minimal Model population analysis: Likelihood function profiling via Monte Carlo sampling.
Matthew L. Zierhut, Marc R. Gastonguay, Steven W. Martin, Paolo Vicini, Pirow J. Bekker, Donna Holloway, Philip T. Leese & Mark C. Peterson. (2008) Population PK–PD model for Fc-osteoprotegerin in healthy postmenopausal women. Journal of Pharmacokinetics and Pharmacodynamics 35:4, pages 379-399.
Crossref
Crossref
Corinne Seng Yue, William Huang, Michelle Alton, Allan N. Maroli, Royce W. Waltrip, David Wright & Marika Di Marco. (2008) Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment-Failure Gout. The Journal of Clinical Pharmacology 48:6, pages 708-718.
Crossref
Crossref
Lei Yang, John C. Panetta, Xiangjun Cai, Wenjian Yang, Deqing Pei, Cheng Cheng, Nancy Kornegay, Ching-Hon Pui & Mary V. Relling. (2008) Asparaginase May Influence Dexamethasone Pharmacokinetics in Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 26:12, pages 1932-1939.
Crossref
Crossref
Anthe S Zandvliet, Jan H M Schellens, Jos H Beijnen & Alwin D R Huitema. (2008) Population Pharmacokinetics and Pharmacodynamics for Treatment Optimization??in Clinical Oncology. Clinical Pharmacokinetics 47:8, pages 487-513.
Crossref
Crossref
Noël Zahr, Zahir Amoura, Jean Debord, Jean-Sébastien Hulot, Franck Saint-Marcoux, Pierre Marquet, Jean Charles Piette & Philippe Lechat. (2008) Pharmacokinetic Study of Mycophenolate Mofetil in Patients with Systemic Lupus Erythematosus and Design of Bayesian Estimator Using Limited Sampling Strategies. Clinical Pharmacokinetics 47:4, pages 277-284.
Crossref
Crossref
Clinton F. Stewart, John C. Panetta, Melinda A. O'Shaughnessy, Stacy L. Throm, Charles H. Fraga, Thandranese Owens, Tiebin Liu, Catherine Billups, Carlos Rodriguez-Galindo, Amar Gajjar, Wayne L. Furman & Lisa M. McGregor. (2007)
UGT1A1
Promoter Genotype Correlates With SN-38 Pharmacokinetics, but Not Severe Toxicity in Patients Receiving Low-Dose Irinotecan
. Journal of Clinical Oncology 25:18, pages 2594-2600.
Crossref
Crossref
Olanrewaju Okusanya, Alan Forrest, Robin DiFrancesco, Sanela Bilic, Susan Rosenkranz, Michael F. Para, Elizabeth Adams, Kevin E. Yarasheski, Richard C. Reichman & Gene D. Morse. (2007) Compartmental Pharmacokinetic Analysis of Oral Amprenavir with Secondary Peaks. Antimicrobial Agents and Chemotherapy 51:5, pages 1822-1826.
Crossref
Crossref
Juliana F. Roos, Jeffrey Lipman & Carl M. J Kirkpatrick. (2007) Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria. Intensive Care Medicine 33:5, pages 781-788.
Crossref
Crossref
Robert J. Bauer, Serge Guzy & Chee Ng. (2007) A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. The AAPS Journal 9:1, pages E60-E83.
Crossref
Crossref
Nobuko HijiyaJohn C. PanettaYinmei ZhouEmily P. KyzerScott C. HowardSima JehaBassem I. RazzoukRaul C. RibeiroJeffrey E. RubnitzMelissa M. HudsonJohn T. SandlundChing-Hon PuiMary V. Relling. (2006) Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 108:13, pages 3997-4002.
Crossref
Crossref
Johannes H. Proost & Douglas J. Eleveld. (2006) Performance of an Iterative Two-Stage Bayesian Technique for Population Pharmacokinetic Analysis of Rich Data Sets. Pharmaceutical Research 23:12, pages 2748-2759.
Crossref
Crossref
Kevin M. Krudys, Steven E. Kahn & Paolo Vicini. (2006) Population approaches to estimate minimal model indexes of insulin sensitivity and glucose effectiveness using full and reduced sampling schedules. American Journal of Physiology-Endocrinology and Metabolism 291:4, pages E716-E723.
Crossref
Crossref
Guillermo Marshall, Rolando De la Cruz-Mesía, Anna E. Barón, James H. Rutledge & Gary O. Zerbe. (2006) Non-linear random effects model for multivariate responses with missing data. Statistics in Medicine 25:16, pages 2817-2830.
Crossref
Crossref
Johannes H Proost & Douglas J Eleveld. (2006) Parametric and Nonparametric Population Methods. Clinical Pharmacokinetics 45:8, pages 851-852.
Crossref
Crossref
Paolo Magni, Giovanni Sparacino, Riccardo Bellazzi & Claudio Cobelli. (2006) Reduced sampling schedule for the glucose minimal model: importance of Bayesian estimation. American Journal of Physiology-Endocrinology and Metabolism 290:1, pages E177-E184.
Crossref
Crossref
Chee M. Ng, Eric Stefanich, Banmeet S. Anand, Paul J. Fielder & Louis Vaickus. (2006) Pharmacokinetics/Pharmacodynamics of Nondepleting Anti-CD4 Monoclonal Antibody (TRX1) in Healthy Human Volunteers. Pharmaceutical Research 23:1, pages 95-103.
Crossref
Crossref
Anny Fourtanier, Dominique Moyal, Jean Maccario, Delphine Compan, Peter Wolf, Franz Quehenberger, Kevin Cooper, Elma Baron, Gary Halliday, Terrence Poon, Paul Seed, Susan L. Walker & Antony R. Young. (2005) Measurement of Sunscreen Immune Protection Factors in Humans: A Consensus Paper. Journal of Investigative Dermatology 125:3, pages 403-409.
Crossref
Crossref
Bernd Meibohm, Stephanie Läer, John C. Panetta & Jeffrey S. Barrett. (2005) Population pharmacokinetic studies in pediatrics: Issues in design and analysis. The AAPS Journal 7:2, pages E475-E487.
Crossref
Crossref
Aurélie Prémaud, Yannick Le Meur, Jean Debord, Jean-Christophe Szelag, Annick Rousseau, Guillaume Hoizey, Olivier Toupance & Pierre Marquet. (2005) Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients at Different Postgrafting Periods. Therapeutic Drug Monitoring 27:3, pages 354-361.
Crossref
Crossref
Mark N. Kirstein, John C. Panetta, Amar Gajjar, Geeta Nair, Lisa C. Iacono, Burgess B. FreemanIIIIII & Clinton F. Stewart. (2005) Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC. Cancer Chemotherapy and Pharmacology 55:5, pages 433-438.
Crossref
Crossref
Goonaseelan (Colin) Pillai, France Mentré & Jean-Louis Steimer. (2005) Non-Linear Mixed Effects Modeling – From Methodology and Software Development to Driving Implementation in Drug Development Science. Journal of Pharmacokinetics and Pharmacodynamics 32:2, pages 161-183.
Crossref
Crossref
Patrick F Smith, Robert DiCenzo, Alan Forrest, Mark Shelton, Gerald Friedland, Michael Para, Richard Pollard, Margaret Fischl, Robin DiFrancesco & Gene D Morse. (2005) Population Pharmacokinetics of Delavirdine and N-Delavirdine in HIV-Infected Individuals. Clinical Pharmacokinetics 44:1, pages 99-109.
Crossref
Crossref
M.E. Wilinska, L.J. Chassin, H.C. Schaller, L. Schaupp, T.R. Pieber & R. Hovorka. (2005) Insulin Kinetics in Type-1 Diabetes: Continuous and Bolus Delivery of Rapid Acting Insulin. IEEE Transactions on Biomedical Engineering 52:1, pages 3-12.
Crossref
Crossref
David Robinson. 2004. Engineering Design Reliability Handbook. Engineering Design Reliability Handbook.
Ene I Ette & Paul J Williams. (2004) Population Pharmacokinetics II: Estimation Methods. Annals of Pharmacotherapy 38:11, pages 1907-1915.
Crossref
Crossref
Yumei Lin, Stephen R Dueker, Jennifer R Follett, James G Fadel, Ali Arjomand, Philip D Schneider, Joshua W Miller, Ralph Green, Bruce A Buchholz, John S Vogel, Robert D Phair & Andrew J Clifford. (2004) Quantitation of in vivo human folate metabolism. The American Journal of Clinical Nutrition 80:3, pages 680-691.
Crossref
Crossref
Malgorzata E. Wilinska, Manfred Bodenlenz, Ludovic J. Chassin, Helga C. Schaller, Lukas A. Schaupp, Thomas R. Pieber & Roman Hovorka. (2004) Interstitial glucose kinetics in subjects with type 1 diabetes under physiologic conditions. Metabolism 53:11, pages 1484-1491.
Crossref
Crossref
Lars Erichsen, Olorunsola F. Agbaje, Stephen D. Luzio, David R. Owens & Roman Hovorka. (2004) Population and individual minimal modeling of the frequently sampled insulin-modified intravenous glucose tolerance test. Metabolism 53:10, pages 1349-1354.
Crossref
Crossref
I?aki F Troc?niz, Jan-Markus Wolters, Hans Guenter Schaefer & Willy Roth. (2004) Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonists. European Journal of Pharmaceutical Sciences 22:4, pages 287-295.
Crossref
Crossref
Alison K. Meagher, Alan Forrest, Axel Dalhoff, Heino Stass & Jerome J. Schentag. (2004) Novel Pharmacokinetic-Pharmacodynamic Model forPrediction of Outcomes with an Extended-Release FormulationofCiprofloxacin. Antimicrobial Agents and Chemotherapy 48:6, pages 2061-2068.
Crossref
Crossref
Kristine R. Crews, Tiebin Liu, Carlos Rodriguez‐Galindo, Ming Tan, William H. Meyer, J. Carl Panetta, Michael P. Link & Najat C. Daw. (2004) High‐dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer 100:8, pages 1724-1733.
Crossref
Crossref
A. Bertoldo, G. Sparacino & C. Cobelli. (2004) ?Population? Approach Improves Parameter Estimation of Kinetic Models From Dynamic PET Data. IEEE Transactions on Medical Imaging 23:3, pages 297-306.
Crossref
Crossref
Robert J. Bauer & Serge Guzy. 2004. Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis Volume 3. Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis Volume 3
135
163
.
Marie Davidian & David M. Giltinan. (2003) Nonlinear models for repeated measurement data: An overview and update. Journal of Agricultural, Biological, and Environmental Statistics 8:4, pages 387-419.
Crossref
Crossref
Beow Yong Yeap, Paul J. Catalano, Louise M. Ryan & Marie Davidian. (2003) Robust two-stage approach to repeated measurements analysis of chronic ozone exposure in rats. Journal of Agricultural, Biological, and Environmental Statistics 8:4, pages 438-454.
Crossref
Crossref
J. Lorenzo Bermejo, R. Roehe, V. Schulze, H. Looft & E. Kalm. (2003) Genetic change of feed intake curves in growing pigs using non-linear two-stage genetic analysis and linear random regression models. Journal of Animal Breeding and Genetics 120:4, pages 217-227.
Crossref
Crossref
Lyonne K van Rossum, Ron A A Mathot, Karlien Cransberg & Arnold G Vulto. (2003) Optimal Sampling Strategies to Assess Inulin Clearance in Children by the Inulin Single-Injection Method. Clinical Chemistry 49:7, pages 1170-1179.
Crossref
Crossref
J. K. Aronson. (2003)
Features of this month's
Journal
. British Journal of Clinical Pharmacology 56:1, pages 1-2.
Crossref
Crossref
Robert DiCenzo, Alan Forrest, Judianne C. Slish, Carol Cole & Ronnie Guillet. (2012) A Gentamicin Pharmacokinetic Population Model and Once‐Daily Dosing Algorithm for Neonates. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23:5, pages 585-591.
Crossref
Crossref
Marı́a J. Garrido, Onintza Sayar, Cristina Segura, Javier Rapado, Marı́a Carmen Dios-Viéitez, Marı́a Jesús Renedo & Iñaki F. Trocóniz. (2003) Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity. Journal of Pharmacology and Experimental Therapeutics 305:2, pages 710-718.
Crossref
Crossref
P.F. Smith, M.C. Birmingham, G.A. Noskin, A.K. Meagher, A. Forrest, C.R. Rayner & J.J. Schentag. (2003) Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Annals of Oncology 14:5, pages 795-801.
Crossref
Crossref
Mathew J. EdickAmar GajjarHazem H. MahmoudMatthijs E.C. van de PollPatricia L. HarrisonJohn C. PanettaGaston K. RiveraRaul C. RibeiroJohn T. SandlundJames M. BoyettChing-Hon PuiMary V. Relling. (2003) Pharmacokinetics and Pharmacodynamics of Oral Etoposide in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 21:7, pages 1340-1346.
Crossref
Crossref
Nelson Jumbe & Michael Miller. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition
109
133
.
Alison K. Meagher, Alan Forrest, Craig R. Rayner, Mary C. Birmingham & Jerome J. Schentag. (2003) Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program. Antimicrobial Agents and Chemotherapy 47:2, pages 548-553.
Crossref
Crossref
Craig R Rayner, Alan Forrest, Alison K Meagher, Mary C Birmingham & Jerome J Schentag. (2003) Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use Programme. Clinical Pharmacokinetics 42:15, pages 1411-1423.
Crossref
Crossref
A. Hamilton, L. Biganzoli, R. Coleman, L. Mauriac, P. Hennebert, A. Awada, M. Nooij, L. Beex, M. Piccart, I. Van Hoorebeeck, P. Bruning & D. de Valeriola. (2002) EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer. Annals of Oncology 13:6, pages 910-918.
Crossref
Crossref
NJ Lacayo, BL Lum, DL Becton, H Weinstein, Y Ravindranath, MN Chang, L Bomgaars, SJ Lauer, BI Sikic & GV Dahl. (2002) Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. Leukemia 16:5, pages 920-927.
Crossref
Crossref
Alexander A. Vinks. (2002) The application of population pharmacokinetic modeling to individualized antibiotic therapy. International Journal of Antimicrobial Agents 19:4, pages 313-322.
Crossref
Crossref
Munther Al-Zaid & Shie-Shien Yang. (2001) An Approximate EM Algorithm for Nonlinear Mixed Effects Models. Biometrical Journal 43:7, pages 881-893.
Crossref
Crossref
Therese A. Stukel, Eugene Demidenko, James Dykes & Margaret R. Karagas. (2001) Two‐stage methods for the analysis of pooled data. Statistics in Medicine 20:14, pages 2115-2130.
Crossref
Crossref
Julie A. Simpson, Leon Aarons & Nicholas J. White. (2001) How can we do pharmacokinetic studies in the tropics?. Transactions of the Royal Society of Tropical Medicine and Hygiene 95:4, pages 347-351.
Crossref
Crossref
Beow Yong Yeap & Marie Davidian. (2004) Robust Two‐Stage Estimation in Hierarchical Nonlinear Models. Biometrics 57:1, pages 266-272.
Crossref
Crossref
Bradley M. Bell. (2001) Approximating the marginal likelihood estimate for models with random parameters. Applied Mathematics and Computation 119:1, pages 57-75.
Crossref
Crossref
Shirya Rashid, Kristine D. Uffelman, P. Hugh R. Barrett, Paolo Vicini, Khosrow Adeli & Gary F. Lewis. (2001) Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits. Journal of Lipid Research 42:2, pages 265-271.
Crossref
Crossref
Paolo Vicini & Claudio Cobelli. (2001) The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling. American Journal of Physiology-Endocrinology and Metabolism 280:1, pages E179-E186.
Crossref
Crossref
Roman Hovorka, Roman Hovorka & Paolo Vicini. 2001. Modeling Methodology for Physiology and Medicine. Modeling Methodology for Physiology and Medicine
107
151
.
Ha Nguyen & Dhammika Amaratunga. 2001. Applied Statistics in the Pharmaceutical Industry. Applied Statistics in the Pharmaceutical Industry
109
133
.
Leland V. Miller, Nancy F. Krebs & K. Michael Hambidge. (2000) Development of a compartmental model of human zinc metabolism: identifiability and multiple studies analyses. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 279:5, pages R1671-R1684.
Crossref
Crossref
Patrick F. SmithAlan ForrestCharles H. BallowDavid E. Martin & Louise Proulx. (2000) Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of BCH-10652 in Healthy Adult Males. Antimicrobial Agents and Chemotherapy 44:10, pages 2816-2823.
Crossref
Crossref
Guenther Hochhaus, Jeffrey S. Barrett & Hartmut Derendorf. (2000) Evolution of Pharmacokinetics and Pharmacokinetic/Dynamic Correlations during the 20th Century. The Journal of Clinical Pharmacology 40:9, pages 908-917.
Crossref
Crossref
Marco L.A. Sivilotti, Michael J. Burns, Kenneth E. McMartin & Jeffrey Brent. (2000) Toxicokinetics of ethylene glycol during fomepizole therapy: Implications for management. Annals of Emergency Medicine 36:2, pages 114-125.
Crossref
Crossref
A Ruggeri & M Martinelli. (2000) A program for the optimization of cyclosporine therapy using population kinetics modeling. Computer Methods and Programs in Biomedicine 61:1, pages 61-69.
Crossref
Crossref
Angela M. Lopez, Mark D. Pegram, Dennis J. Slamon & Elliot M. Landaw. (1999)
A model-based approach for assessing
in vivo
combination therapy interactions
. Proceedings of the National Academy of Sciences 96:23, pages 13023-13028.
Crossref
Crossref
S G MachadoR Miller & C Hu. (2016) A regulatory perspective on pharmacokinetic/pharmacodynamic modelling. Statistical Methods in Medical Research 8:3, pages 217-245.
Crossref
Crossref
Akifumi Yafune & Makio Ishiguro. (1999) Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. II: a bootstrap modification of standard two-stage (STS) method for phase I trial. Statistics in Medicine 18:5, pages 601-612.
Crossref
Crossref
Akifumi Yafune & Makio Ishiguro. (1999) Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: a use of bootstrap standard error. Statistics in Medicine 18:5, pages 581-599.
Crossref
Crossref
M Amantea, M S Newman, T M Sullivan, A Forrest & P K Working. (2016) Relationship of dose intensity to the induction of palmar-plantar erythrodysesthia by pegylated liposomal doxorubicin in dogs. Human & Experimental Toxicology 18:1, pages 17-26.
Crossref
Crossref
Terence Fullerton, Denise Komorowski‐Swiatek, Alan Forrest & Fran M. Gengo. (2013) The Pharmacodynamics of Sumatriptan in Nitroglycerin‐Induced Headache. The Journal of Clinical Pharmacology 39:1, pages 17-29.
Crossref
Crossref
Meryl E. Wastney, Blossom H. Patterson, Oscar A. Linares, Peter C. Greif & Ray C. Boston. 1999. Investigating Biological Systems Using Modeling. Investigating Biological Systems Using Modeling
257
274
.
Stephen C. Piscitelli, Alan Forrest, Susan Vogel, Doreen Chaitt, Julia Metcalf, Randy Stevens, Michael Baseler, Richard T. Davey & Joseph A. Kovacs. (1998) Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection. Clinical Pharmacology & Therapeutics 64:5, pages 492-498.
Crossref
Crossref
Merrill J. Egorin. (1998) Overview of recent topics in clinical pharmacology of anticancer agents. Cancer Chemotherapy and Pharmacology 42:S1, pages S22-S30.
Crossref
Crossref
T. MARTÍN‐JIMÉNEZ & J.E. RIVIERE. (2002) Population pharmacokinetics in veterinary medicine: Potential use for therapeutic drug monitoring and prediction of tissue residues. Journal of Veterinary Pharmacology and Therapeutics 21:3, pages 167-189.
Crossref
Crossref
Florence Patron-Bizet, France Mentr?Michel Genton, Corinne Thomas-Haimez & Jean Maccario. (1998) Assessment of the global two-stage method to EC50 determination. Journal of Pharmacological and Toxicological Methods 39:2, pages 103-108.
Crossref
Crossref
Amy Racine-PoonJon Wakefield. (2016) Statistical methods for population pharmacokinetic modelling. Statistical Methods in Medical Research 7:1, pages 63-84.
Crossref
Crossref
Marilou I. Ching, Bong Hee Sung, Alan Forrest, Michael F. Wilson & Joseph L. IzzoJr.Jr.. (1998) Vasoreactivity in Pre- and Postmenopausal Women: Evaluation by Pharmacodynamic Modeling. The Journal of Clinical Pharmacology 38:2, pages 151-159.
Crossref
Crossref
S. O’Reilly, S.D. Baker, S. Sartorius, E.K. Rowinsky, M. Finizio, G.M. Lubiniecki, L.B. Grochow, J.E. Gray, H.I. PieniaszekJrJr & R.C. Donehower. (1998) A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion. Annals of Oncology 9:1, pages 101-104.
Crossref
Crossref
Paolo Vicini, P. Hugh, R. Barrett, Claudio Cobelli, David M. Foster & Alan Schumitzky. 1998. Mathematical Modeling in Experimental Nutrition. Mathematical Modeling in Experimental Nutrition
103
113
.
Stephen C. Piscitelli, Alan Forrest, Richard M. Lush, Nathan Ryan, Lloyd R. Whitfield & William D. Figg. (2012) Pharmacometric Analysis of the Effect of Furosemide on Suramin Pharmacokinetics. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17:3, pages 431-437.
Crossref
Crossref
Rajeshwari Sridhara, Mario A. Eisenberger, Leonard M. Reyno, Duncan I. Jodrell, Victoria J. Sinibaldi, Eleanor G. Zubowski & Merrill J. Egorin. (1997) Comparison of Iterative-Two Stage and Bootstrap Sampling Approaches in the Development of a Population Pharmacokinetic Model. IFAC Proceedings Volumes 30:2, pages 141-145.
Crossref
Crossref
Michael A. Amantea, Alan Forrest, Donald W. Northfelt & Richard Mamelok. (1997) Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. Clinical Pharmacology & Therapeutics 61:3, pages 301-311.
Crossref
Crossref
Thérèse A. Stukel & Eugene Demidenko. 1997. Modelling Longitudinal and Spatially Correlated Data. Modelling Longitudinal and Spatially Correlated Data
135
146
.
A D KashubaC H BallowA Forrest. (1996) Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidime. Antimicrobial Agents and Chemotherapy 40:8, pages 1860-1865.
Crossref
Crossref
J. E. Bennett & J. C. Wakefield. (1996) A comparison of a bayesian population method with two methods as implemented in commercially available software. Journal of Pharmacokinetics and Biopharmaceutics 24:4, pages 403-432.
Crossref
Crossref
J M JacobsonM DavidianP M RaineyR HafnerR H RaaschB J Luft. (1996) Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 40:6, pages 1360-1365.
Crossref
Crossref
Terrence Fullerton, Alan Forrest & Gerhard Levy. (1996) Pharmacodynamic Analysis of Sparse Data from Concentration- and Effect-Controlled Clinical Trials Guided by a Pilot Study. An Investigation by Simulations. Journal of Pharmaceutical Sciences 85:6, pages 600-607.
Crossref
Crossref
Michel Tod & Jean-Marie Rocchisani. (1996) Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria. Computer Methods and Programs in Biomedicine 50:1, pages 13-22.
Crossref
Crossref
B G ReignerH A Welker. (1996) Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studies. Antimicrobial Agents and Chemotherapy 40:3, pages 575-580.
Crossref
Crossref
S C Piscitelli, M A Amatea, S Vogel, C Bechtel, J A Metcalf & J A Kovacs. (1996) Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines. Antimicrobial Agents and Chemotherapy 40:1, pages 161-165.
Crossref
Crossref
Donald W. Northfelt, Francis J. Martin, Peter Working, Paul A. Volberding, Julie Russell, Mary Newman, Michael A. Amantea & Lawrence D. Kaplan. (2013) Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma. The Journal of Clinical Pharmacology 36:1, pages 55-63.
Crossref
Crossref
M. Cociglio, D. Hillaire-Buys & C. Alric. (1995) Determination of methotrexate and 7-hydroxymethotrexate by liquid chromatography for routine monitoring of plasma levels. Journal of Chromatography B: Biomedical Sciences and Applications 674:1, pages 101-110.
Crossref
Crossref
M A AmanteaR A BowdenA ForrestP K WorkingM S NewmanR D Mamelok. (1995) Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants. Antimicrobial Agents and Chemotherapy 39:9, pages 2042-2047.
Crossref
Crossref
G L DrusanoW LiuR PerkinsA MaduC MaduM MayersM H Miller. (1995) Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program. Antimicrobial Agents and Chemotherapy 39:8, pages 1683-1687.
Crossref
Crossref
Nicola G. Best, Keith K. C. Tan, Wally R. Gilks & David J. Spiegelhalter. (1995) Estimation of population pharmacokinetics using the Gibbs sampler. Journal of Pharmacokinetics and Biopharmaceutics 23:4, pages 407-435.
Crossref
Crossref
Rogelio Q. Ramos & Sastry G. Pantula. (1995) Estimation of nonlinear random coefficient models. Statistics & Probability Letters 24:1, pages 49-56.
Crossref
Crossref
Harry Mager & Gernot Göller. (2007) ANALYSIS OF PSEUDO‐PROFILES IN ORGAN PHARMACOKINETICS AND TOXICOKINETICS. Statistics in Medicine 14:9, pages 1009-1024.
Crossref
Crossref
Pascal Girard, Silvy Laporte‐Simitsidis, Patrick Mismetti, Hervé Decousus & Jean‐Pierre Boissel. (2007) INFLUENCE OF CONFOUNDING FACTORS ON DESIGNS FOR DOSE–EFFECT RELATIONSHIP ESTIMATES. Statistics in Medicine 14:9, pages 987-1005.
Crossref
Crossref
Jerry R. Nedelman, Adel H. Karara, Cheng‐Tao Chang, Ekaterina Gibiansky, Scott McDonald & William T. Robinson. (2007) INFERRING SYSTEMIC EXPOSURE FROM A PHARMACOKINETIC SCREEN: MODEL‐FREE AND MODEL‐BASED APPROACHES. Statistics in Medicine 14:9, pages 955-968.
Crossref
Crossref
J Falloon, J Lavelle, D Ogata-Arakaki, A Byrne, A Graziani, A Morgan, M A Amantea, K Ownby, M Polis & R T Davey. (1994) Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.. Antimicrobial Agents and Chemotherapy 38:7, pages 1580-1587.
Crossref
Crossref
David M. Giltinan & Marie Davidian. (2006) Assays for recombinant proteins: A problem in non‐linear calibration. Statistics in Medicine 13:11, pages 1165-1179.
Crossref
Crossref
J. P. Ordov?s, C. L. Ronchera, J. L. Poveda, N. V. Jim?nez & R. L?pez. (1994) Selection of optimal prophylactic aminoglycoside dosage in cancer patients: population pharmacokinetic approaches. Journal of Clinical Pharmacy and Therapeutics 19:1, pages 47-56.
Crossref
Crossref
J. J. Schentag. 1994. Ciprofloxacin i.v.. Ciprofloxacin i.v.
49
61
.
D DeMuriaA ForrestJ RichJ M ScavoneL G CohenP H Kazanjian. (1993) Pharmacokinetics and bioavailability of fluconazole in patients with AIDS. Antimicrobial Agents and Chemotherapy 37:10, pages 2187-2192.
Crossref
Crossref
W. R. Gilks, D. G. Clayton, D. J. Spiegelhalter, N. G. Best, A. J. McNeil, L. D. Sharples & A. J. Kirby. (1993) Modelling Complexity: Applications of Gibbs Sampling in Medicine. Journal of the Royal Statistical Society: Series B (Methodological) 55:1, pages 39-52.
Crossref
Crossref
Leon Aarons. (1993) The estimation of population pharmacokinetic parameters using an EM algorithm. Computer Methods and Programs in Biomedicine 41:1, pages 9-16.
Crossref
Crossref
Marie Davidian & David M. Giltinan. (1993) Analysis of repeated measurement data using the nonlinear mixed effects model. Chemometrics and Intelligent Laboratory Systems 20:1, pages 1-24.
Crossref
Crossref
A ForrestD E NixC H BallowT F GossM C BirminghamJ J Schentag. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37:5, pages 1073-1081.
Crossref
Crossref
A ForrestC H BallowD E NixM C BirminghamJ J Schentag. (1993) Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrobial Agents and Chemotherapy 37:5, pages 1065-1072.
Crossref
Crossref
T M GilmanS R BrunnemannJ L Segal. (1993) Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients. Antimicrobial Agents and Chemotherapy 37:1, pages 93-99.
Crossref
Crossref
David C. Smith, Duncan I. Jodrell, Merrill J. Egorin, Roy M. Ambinder, Eleanor G. Zuhowski, Willi Kreis, Peter G. Ellis & Donald L. Trump. (1993) Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer. Cancer Chemotherapy and Pharmacology 31:5, pages 363-368.
Crossref
Crossref
Rosemarie Mick & Mark J. Ratain. (1993) Statistical approaches to pharmacodynamic modeling: motivations, methods, and misperceptions. Cancer Chemotherapy and Pharmacology 33:1, pages 1-9.
Crossref
Crossref
Marie Davidian & A. Ronald Gallant. (1992) Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine. Journal of Pharmacokinetics and Biopharmaceutics 20:5, pages 529-556.
Crossref
Crossref
Mark E. Sale & Terrence F. Blaschke. (2016) Incorporating Pharmacokinetic/Pharmacodynamic Modeling in Drug Development—Are We Ready?. Drug Information Journal 26:1, pages 119-124.
Crossref
Crossref
Amy Racine-Poon. 1992. Computational Statistics. Computational Statistics
523
531
.
Merrill J. Egorin. 1992. New Approaches in Cancer Pharmacology: Drug Design and Development. New Approaches in Cancer Pharmacology: Drug Design and Development
75
91
.
A. M. Skene & S. A. White. (2007) A latent class model for repeated measurements experiments. Statistics in Medicine 11:16, pages 2111-2122.
Crossref
Crossref
L Aarons. (2012) Population pharmacokinetics: theory and practice.. British Journal of Clinical Pharmacology 32:6, pages 669-670.
Crossref
Crossref
Willi Weber, Susanne Toussaint, Michael Looby, Manfred Nitz & Helmut Kewitz. (1991) System analysis in multiple dose kinetics: Evidence for saturable tubular reabsorption of the organic cationN 1-methylnicotinamide in humans. Journal of Pharmacokinetics and Biopharmaceutics 19:5, pages 553-574.
Crossref
Crossref
A. M. Skene & J. C. Wakefield. (2006) Hierarchical models for multicentre binary response studies. Statistics in Medicine 9:8, pages 919-929.
Crossref
Crossref
E. Walter & L. Pronzato. (1990) Qualitative and quantitative experiment design for phenomenological models—A survey. Automatica 26:2, pages 195-213.
Crossref
Crossref
LUC P. BALANT, HENK ROSEBOOM & URSULA M. GUNDERT-REMY. 1990.
1
138
.
Donald BerryAmy Racine-Poon & Adrian Smith. 1989. Statistical Methodology in the Pharmaceutical Sciences. Statistical Methodology in the Pharmaceutical Sciences
139
162
.
E. Walter & L. Pronzato. (1988) Qualitative and Quantitative Experiment Design for Nonlinear Models. IFAC Proceedings Volumes 21:1, pages 69-80.
Crossref
Crossref
Eugene Demidenko. 1987. Mixed Models. Mixed Models
681
709
.
. (1986)
Discussion of the Paper by Mr. Racine
et al
.
. Journal of the Royal Statistical Society Series C: Applied Statistics 35:2, pages 121-150.
Crossref
Crossref
Lewis B. Sheiner. (1985) Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters. Journal of Pharmacokinetics and Biopharmaceutics 13:5, pages 515-540.
Crossref
Crossref